(Q50266714)

28 February 2018

title

Macrophages Facilitate Resistance to Anti-VEGF Therapy by Altered VEGFR Expression (English)

1 reference

28 February 2018

19

Michael Andreeff

1 reference

28 February 2018

25

Anil K Sood

1 reference

28 February 2018

author name string

Heather J Dalton

1

1 reference

28 February 2018

Sunila Pradeep

2

1 reference

28 February 2018

Michael McGuire

3

1 reference

28 February 2018

Yared Hailemichael

4

1 reference

28 February 2018

Shaolin Ma

5

1 reference

28 February 2018

Yasmin Lyons

6

1 reference

28 February 2018

Guillermo N Armaiz-Pena

7

1 reference

28 February 2018

Rebecca A Previs

8

1 reference

28 February 2018

Jean Marie Hansen

9

1 reference

28 February 2018

Rajesha Rupaimoole

10

1 reference

28 February 2018

Vianey Gonzalez-Villasana

11

1 reference

28 February 2018

Min Soon Cho

12

1 reference

28 February 2018

Sherry Y Wu

13

1 reference

28 February 2018

Lingegowda S Mangala

14

1 reference

28 February 2018

Nicholas B Jennings

15

1 reference

28 February 2018

Wei Hu

16

1 reference

28 February 2018

Robert Langley

17

1 reference

28 February 2018

Hong Mu

18

1 reference

28 February 2018

Menashe Bar-Eli

20

1 reference

28 February 2018

Willem Overwijk

21

1 reference

28 February 2018

Prahlad Ram

22

1 reference

28 February 2018

Gabriel Lopez-Berestein

23

1 reference

28 February 2018

Robert L Coleman

24

1 reference

28 February 2018

language of work or name

English

0 references

publication date

29 August 2017

1 reference

28 February 2018

published in

Clinical Cancer Research

1 reference

28 February 2018

volume

23

1 reference

28 February 2018

issue

22

1 reference

28 February 2018

page(s)

7034-7046

1 reference

28 February 2018

Distinct bone marrow-derived and tissue-resident macrophage lineages proliferate at key stages during inflammation

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5690831

Macrophage regulation of tumor responses to anticancer therapies

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5690831

Chemotherapy alters monocyte differentiation to favor generation of cancer-supporting M2 macrophages in the tumor microenvironment

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5690831

Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5690831

Effects of bone-targeted agents on cancer progression and mortality.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5690831

Anti-VEGF/VEGFR therapy for cancer: reassessing the target

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5690831

Bisphosphonates and other bone agents for breast cancer

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5690831

A phase 3 trial of bevacizumab in ovarian cancer

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5690831

Incorporation of bevacizumab in the primary treatment of ovarian cancer

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5690831

Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5690831

Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5690831

Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5690831

Drugs which inhibit osteoclast function suppress tumor growth through calcium reduction in bone.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5690831

Bisphosphonates' antitumor activity: an unravelled side of a multifaceted drug class.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5690831

Recruitment of myeloid but not endothelial precursor cells facilitates tumor regrowth after local irradiation

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5690831

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5690831

Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5690831

Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5690831

Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5690831

American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5690831

Rapid vascular regrowth in tumors after reversal of VEGF inhibition

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5690831

VEGF as a therapeutic target in cancer

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5690831

Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5690831

EphA2 expression is associated with aggressive features in ovarian carcinoma

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5690831

Antibody to vascular endothelial growth factor slows growth of an androgen-independent xenograft model of prostate cancer

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5690831

Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5690831

29 September 2018

The Hallmarks of Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5690831

Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5690831

Role of Macrophage Targeting in the Antitumor Activity of Trabectedin

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5690831

10.1158/1078-0432.CCR-17-0647

30 November 2018

Identifiers

DOI

1 reference

28 February 2018

PMC publication ID

5690831

0 references

1 reference

28 February 2018